°£Æí°áÁ¦, ½Å¿ëÄ«µå û±¸ÇÒÀÎ
ÀÎÅÍÆÄÅ© ·Ôµ¥Ä«µå 5% (35,570¿ø)
(ÃÖ´ëÇÒÀÎ 10¸¸¿ø / Àü¿ù½ÇÀû 40¸¸¿ø)
ºÏÇǴϾð ·Ôµ¥Ä«µå 30% (26,210¿ø)
(ÃÖ´ëÇÒÀÎ 3¸¸¿ø / 3¸¸¿ø ÀÌ»ó °áÁ¦)
NH¼îÇÎ&ÀÎÅÍÆÄÅ©Ä«µå 20% (29,960¿ø)
(ÃÖ´ëÇÒÀÎ 4¸¸¿ø / 2¸¸¿ø ÀÌ»ó °áÁ¦)
Close

Çٽɸ鿪ÇÐ : ¸é¿ªÃ¼°èÀÇ ±â´É ¹× Àå¾Ö

¿øÁ¦ : Basic Immunology
¼Òµæ°øÁ¦

2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.

ÆǸÅÁö¼ö 51
?
ÆǸÅÁö¼ö¶õ?
»çÀÌÆ®ÀÇ ÆǸŷ®¿¡ ±â¹ÝÇÏ¿© ÆǸŷ® ÃßÀ̸¦ ¹Ý¿µÇÑ ÀÎÅÍÆÄÅ© µµ¼­¿¡¼­ÀÇ µ¶¸³ÀûÀÎ ÆǸŠÁö¼öÀÔ´Ï´Ù. ÇöÀç °¡Àå Àß Æȸ®´Â »óÇ°¿¡ °¡ÁßÄ¡¸¦ µÎ¾ú±â ¶§¹®¿¡ ½ÇÁ¦ ´©Àû ÆǸŷ®°ú´Â ´Ù¼Ò Â÷ÀÌ°¡ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ÆǸŷ® ¿Ü¿¡µµ ´Ù¾çÇÑ °¡ÁßÄ¡·Î ±¸¼ºµÇ¾î ÃÖ±ÙÀÇ À̽´µµ¼­ È®Àνà À¯¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇØ´ç Áö¼ö´Â ¸ÅÀÏ °»½ÅµË´Ï´Ù.
Close
°øÀ¯Çϱâ
Á¤°¡

39,000¿ø

  • 37,440¿ø (4%ÇÒÀÎ)

ÇÒÀÎÇýÅÃ
Àû¸³ÇýÅÃ
  • S-Point Àû¸³Àº ¸¶ÀÌÆäÀÌÁö¿¡¼­ Á÷Á¢ ±¸¸ÅÈ®Á¤ÇϽŠ°æ¿ì¸¸ Àû¸³ µË´Ï´Ù.
Ãß°¡ÇýÅÃ
¹è¼ÛÁ¤º¸
  • 5/16(¸ñ) À̳» ¹ß¼Û ¿¹Á¤  (¼­¿ï½Ã °­³²±¸ »ï¼º·Î 512)
  • ¹«·á¹è¼Û
ÁÖ¹®¼ö·®
°¨¼Ò Áõ°¡
  • À̺¥Æ®/±âȹÀü

  • ¿¬°üµµ¼­

  • »óÇ°±Ç

AD

Ã¥¼Ò°³

¢º ¡ºÇٽɸ鿪ÇС»Àº ¿¡ ´ëÇØ ´Ù·é µµ¼­·Î¼­ Çٽɸ鿪Çп¡¼­ÀÇ ¸é¿ªÃ¼°è ±â´É ¹× Àå¾ÖÀÇ ±âÃÊÀûÀÌ°í Àü¹ÝÀûÀÎ ³»¿ëÀ» È®ÀÎÇÒ ¼ö ÀÖµµ·Ï ±¸¼ºÇß½À´Ï´Ù.

ÃâÆÇ»ç ¼­Æò

ù°, ÀúÀÚ´Â ¸é¿ªÇÐ ºÐ¾ßÀÇ ¹æ´ëÇÑ ¾çÀÇ ½ÇÇè °á°ú·ÎºÎÅÍ Áß¿äÇÑ °³³äµéÀ» Á¾ÇÕÇÏ¿© ¸é¿ªÃ¼°èÀÇ ÁÖµÈ ¿ø¸®µéÀ» ¼Ò°³ÇÏ°íÀÚ ÇÏ¿´´Ù. ¹«¾ùÀÌ Áß¿äÇÑ °ÍÀÎÁö´Â ÁÖ·Î ½ÇÇèÀ» ÅëÇØ °¡Àå ¸íÈ®ÇÏ°Ô ÀÔÁõµÈ °Í°ú ¸é¿ªÃ¼°èÀÇ ÁÖ±â´ÉÀ» ÀÌÇØÇÏ´Â µ¥ ÇʼöÀûÀÎ °ÍÀ» ±âÁØÀ¸·Î °áÁ¤µÇ¾ú´Ù. ¶ÇÇÑ »ç¶÷ÀÇ °Ç°­°ú Áúº´¿¡ °üÇÑ ³»¿ëÀ» Áß½ÃÇÏ¿´´Ù.
µÑ°, °¨¿°¼º ¹Ì»ý¹°¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ¿¡ ÃÊÁ¡À» ¸ÂÃß¾úÀ¸¸ç, ¸é¿ªÃ¼°è¿¡ ´ëÇÑ ³íÀÇÀÇ ´ëºÎºÐÀº ÀÌ·¯ÇÑ ¸Æ¶ô¿¡¼­ ÀÌ·ç¾îÁ³´Ù.
¼Â°, ±×¸²À» ¾Æ³¦¾øÀÌ È°¿ëÇÔÀ¸·Î½á Áß¿äÇÑ ¿ø¸®¸¦ °­Á¶ÇÏ¿´Áö¸¸, ½ÉÈ­µÈ ±³Àç¿¡¼­ ã¾Æº¼ ¼ö ÀÖ´Â »ó¼¼ÇÑ »ç½ÇµéÀº ÁÙ¿´´Ù.
³Ý°, ¸é¿ªÁúȯµéÀ» ¿ø¸®¿¡ ÀÔ°¢ÇÑ ½Ã°¢¿¡¼­µµ ³íÀÇÇÏ¿© Á¤»ó ¸é¿ª¹ÝÀÀ°úÀÇ ¿¬°ü¼ºÀ» °­Á¶Çϸ鼭 ÀÓ»ó Áõ»ó°ú Ä¡·á¿¡ ´ëÇؼ­´Â »ó¼¼ÇÏ°Ô ´Ù·çÁö ¾Ê¾Ò´Ù. ºÎ·ÏÀ¸·Î ÀÓ»ó »ç·Ê¸¦ Ãß°¡ÇÏ¿´´Âµ¥, ÀÌ´Â ¸é¿ªÇÐÀÇ ¿ø¸®µéÀÌ ¾î¶»°Ô »ç¶÷ÀÇ ÀϹÝÀûÀÎ Áúȯ¿¡ Àû¿ëµÉ ¼ö ÀÖ´ÂÁö¸¦ ¼³¸íÇϱâ À§ÇÔÀÌ´Ù.
¸¶Áö¸·À¸·Î °¢ ÀåµéÀÌ µ¶¸³ÀûÀ¸·Î ÀÐÈú ¼ö ÀÖµµ·Ï Ã¥ÀÇ ¿©·¯ °÷¿¡ ÁÖ¿ä °³³äµéÀ» ¹Ýº¹ ±â¼úÇÏ¿´´Ù. ÀÌ·¯ÇÑ ¹Ýº¹À» ÅëÇØ ÇлýµéÀÌ Áß¿äÇÑ °³³äÀ» ÃæºÐÈ÷ ÆľÇÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢ÇÑ´Ù.

ù°, ÀúÀÚ´Â ¸é¿ªÇÐ ºÐ¾ßÀÇ ¹æ´ëÇÑ ¾çÀÇ ½ÇÇè °á°ú·ÎºÎÅÍ Áß¿äÇÑ °³³äµéÀ» Á¾ÇÕÇÏ¿© ¸é¿ªÃ¼°èÀÇ ÁÖµÈ ¿ø¸®µéÀ» ¼Ò°³ÇÏ°íÀÚ ÇÏ¿´´Ù. ¹«¾ùÀÌ Áß¿äÇÑ °ÍÀÎÁö´Â ÁÖ·Î ½ÇÇèÀ» ÅëÇØ °¡Àå ¸íÈ®ÇÏ°Ô ÀÔÁõµÈ °Í°ú ¸é¿ªÃ¼°èÀÇ ÁÖ±â´ÉÀ» ÀÌÇØÇÏ´Â µ¥ ÇʼöÀûÀÎ °ÍÀ» ±âÁØÀ¸·Î °áÁ¤µÇ¾ú´Ù. ¶ÇÇÑ »ç¶÷ÀÇ °Ç°­°ú Áúº´¿¡ °üÇÑ ³»¿ëÀ» Áß½ÃÇÏ¿´´Ù.
µÑ°, °¨¿°¼º ¹Ì»ý¹°¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ¿¡ ÃÊÁ¡À» ¸ÂÃß¾úÀ¸¸ç, ¸é¿ªÃ¼°è¿¡ ´ëÇÑ ³íÀÇÀÇ ´ëºÎºÐÀº ÀÌ·¯ÇÑ ¸Æ¶ô¿¡¼­ ÀÌ·ç¾îÁ³´Ù.
¼Â°, ±×¸²À» ¾Æ³¦¾øÀÌ È°¿ëÇÔÀ¸·Î½á Áß¿äÇÑ ¿ø¸®¸¦ °­Á¶ÇÏ¿´Áö¸¸, ½ÉÈ­µÈ ±³Àç¿¡¼­ ã¾Æº¼ ¼ö ÀÖ´Â »ó¼¼ÇÑ »ç½ÇµéÀº ÁÙ¿´´Ù.
³Ý°, ¸é¿ªÁúȯµéÀ» ¿ø¸®¿¡ ÀÔ°¢ÇÑ ½Ã°¢¿¡¼­µµ ³íÀÇÇÏ¿© Á¤»ó ¸é¿ª¹ÝÀÀ°úÀÇ ¿¬°ü¼ºÀ» °­Á¶Çϸ鼭 ÀÓ»ó Áõ»ó°ú Ä¡·á¿¡ ´ëÇؼ­´Â »ó¼¼ÇÏ°Ô ´Ù·çÁö ¾Ê¾Ò´Ù. ºÎ·ÏÀ¸·Î ÀÓ»ó »ç·Ê¸¦ Ãß°¡ÇÏ¿´´Âµ¥, ÀÌ´Â ¸é¿ªÇÐÀÇ ¿ø¸®µéÀÌ ¾î¶»°Ô »ç¶÷ÀÇ ÀϹÝÀûÀÎ Áúȯ¿¡ Àû¿ëµÉ ¼ö ÀÖ´ÂÁö¸¦ ¼³¸íÇϱâ À§ÇÔÀÌ´Ù.
¸¶Áö¸·À¸·Î °¢ ÀåµéÀÌ µ¶¸³ÀûÀ¸·Î ÀÐÈú ¼ö ÀÖµµ·Ï Ã¥ÀÇ ¿©·¯ °÷¿¡ ÁÖ¿ä °³³äµéÀ» ¹Ýº¹ ±â¼úÇÏ¿´´Ù. ÀÌ·¯ÇÑ ¹Ýº¹À» ÅëÇØ ÇлýµéÀÌ Áß¿äÇÑ °³³äÀ» ÃæºÐÈ÷ ÆľÇÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢ÇÑ´Ù.

¸ñÂ÷

ÀúÀÚ ¼­¹®_Preface iii
CHAPTER 01 ¸é¿ªÃ¼°èÀÇ °³¿ä_Introduction to the Immune System 1
¸í¸í¹ý, ÀϹÝÀû Ư¼º, ±¸¼º¿ä¼Ò_Nomenclature, General Properties, and Components
CHAPTER 02 ¼±Ãµ¸é¿ª_Innate Immunity 23
°¨¿°¿¡ ´ëÇÑ Ãʱâ¹æ¾î_The Early Defense Against Infections
CHAPTER 03 Ç׿øÀÇ Æ÷ȹ°ú ¸²ÇÁ±¸·ÎÀÇ Á¦½Ã
_Antigen Capture and Presentation to Lymphocytes 53
¸²ÇÁ±¸°¡ º¸´Â °Íµé_ What Lymphocytes See
CHAPTER 04 ÀûÀÀ¸é¿ªÃ¼°èÀÇ Ç׿ø ÀÎÁö
_Antigen Recognition in the Adaptive Immune System 77
¸²ÇÁ±¸ Ç׿ø¼ö¿ëüÀÇ ±¸Á¶ ¹× ¸é¿ª ·¹ÆÛÅ丮ÀÇ ¹ß»ý
_Structure of Lymphocyte Antigen Receptors and Development of Immune Repertoires
CHAPTER 05 T¼¼Æ÷¸Å°³¸é¿ª_T Cell-Mediated Immunity 101
T¸²ÇÁ±¸ È°¼ºÈ­_Activation of T Lymphocytes
CHAPTER 06 T¼¼Æ÷¸Å°³¸é¿ªÀÇ ÀÛµ¿±âÀÛ
_Effector Mechanisms of T Cell–Mediated Immunity 127
¼÷ÁÖ ¹æ¾î¿¡ À־ T¼¼Æ÷ÀÇ ±â´É_Functions of T Cells in Host Defense
CHAPTER 07 ü¾×¸é¿ª¹ÝÀÀ_Humoral Immune Responses 145
B¸²ÇÁ±¸ È°¼ºÈ­¿Í Ç×ü »ý»ê_Activation of B Lymphocytes and Production of Antibodies
CHAPTER 08 ü¾×¸é¿ªÀÇ ÀÛµ¿±âÀÛ_Effector Mechanisms of Humoral Immunity 167
¼¼Æ÷¿Ü¹Ì»ý¹° ¹× µ¶¼ÒÀÇ Á¦°Å_Elimination of Extracellular Microbes and Toxins
CHAPTER 09 ¸é¿ª°ü¿ë°ú ÀÚ°¡¸é¿ª_Immunological Tolerance and Autoimmunity 189
¸é¿ªÃ¼°èÀÇ Àڱ►ñÀڱ⠱¸º° ¹× ±¸º°ÀÇ ½ÇÆÐ
_Self-Nonself Discrimination in the Immune System and Its Failure
CHAPTER 10 Á¾¾ç°ú À̽ÄÀå±â¿¡ ´ëÇÑ ¸é¿ªÇÐ
_Immunology of Tumors and Transplantation 209
¾Ï¼¼Æ÷ ¹× Á¤»ó ¿Ü·¡¼¼Æ÷¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ
_Immune Responses to Cancer Cells and Normal Foreign Cells
CHAPTER 11 °ú¹Î¹ÝÀÀ_Hypersensitivity 233
¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÑ ½Åü±â´ÉÀÇ Àå¾Ö_Disorders Caused by Immune Responses
CHAPTER 12 ¼±Ãµ ¹× ÈÄõ¸é¿ª°áÇÌÁúȯ_Congenital and Acquired Immunodeficiencies 253
¸é¿ª °áÇÔÀ¸·Î ÀϾ´Â Áúȯ_Diseases Caused by Defective Immunity
Âü°í¹®Çå_Selected Readings 271
¿ë¾îÇؼ³_Glossary 287
APPENDIX I ÁÖ¿ä CDºÐÀÚÀÇ ÇÙ½É Æ¯Â¡_Principal Features of Selected CD Molecules 337
APPENDIX II »çÀÌÅäÄ«ÀÎ_Cytokines 345
APPENDIX III ÀÓ»ó »ç·Ê_Clinical Cases 349
ã¾Æº¸±â_Index 363

ÀúÀÚ ¼­¹®_Preface iii

CHAPTER 01 ¸é¿ªÃ¼°èÀÇ °³¿ä_Introduction to the Immune System 1
¸í¸í¹ý, ÀϹÝÀû Ư¼º, ±¸¼º¿ä¼Ò_Nomenclature, General Properties, and Components

CHAPTER 02 ¼±Ãµ¸é¿ª_Innate Immunity 23
°¨¿°¿¡ ´ëÇÑ Ãʱâ¹æ¾î_The Early Defense Against Infections

CHAPTER 03 Ç׿øÀÇ Æ÷ȹ°ú ¸²ÇÁ±¸·ÎÀÇ Á¦½Ã
_Antigen Capture and Presentation to Lymphocytes 53
¸²ÇÁ±¸°¡ º¸´Â °Íµé_ What Lymphocytes See

CHAPTER 04 ÀûÀÀ¸é¿ªÃ¼°èÀÇ Ç׿ø ÀÎÁö
_Antigen Recognition in the Adaptive Immune System 77
¸²ÇÁ±¸ Ç׿ø¼ö¿ëüÀÇ ±¸Á¶ ¹× ¸é¿ª ·¹ÆÛÅ丮ÀÇ ¹ß»ý
_Structure of Lymphocyte Antigen Receptors and Development of Immune Repertoires

CHAPTER 05 T¼¼Æ÷¸Å°³¸é¿ª_T Cell-Mediated Immunity 101
T¸²ÇÁ±¸ È°¼ºÈ­_Activation of T Lymphocytes

CHAPTER 06 T¼¼Æ÷¸Å°³¸é¿ªÀÇ ÀÛµ¿±âÀÛ
_Effector Mechanisms of T Cell-Mediated Immunity 127
¼÷ÁÖ ¹æ¾î¿¡ À־ T¼¼Æ÷ÀÇ ±â´É_Functions of T Cells in Host Defense

CHAPTER 07 ü¾×¸é¿ª¹ÝÀÀ_Humoral Immune Responses 145
B¸²ÇÁ±¸ È°¼ºÈ­¿Í Ç×ü »ý»ê_Activation of B Lymphocytes and Production of Antibodies

CHAPTER 08 ü¾×¸é¿ªÀÇ ÀÛµ¿±âÀÛ_Effector Mechanisms of Humoral Immunity 167
¼¼Æ÷¿Ü¹Ì»ý¹° ¹× µ¶¼ÒÀÇ Á¦°Å_Elimination of Extracellular Microbes and Toxins

CHAPTER 09 ¸é¿ª°ü¿ë°ú ÀÚ°¡¸é¿ª_Immunological Tolerance and Autoimmunity 189
¸é¿ªÃ¼°èÀÇ ÀÚ±â-ºñÀڱ⠱¸º° ¹× ±¸º°ÀÇ ½ÇÆÐ
_Self-Nonself Discrimination in the Immune System and Its Failure

CHAPTER 10 Á¾¾ç°ú À̽ÄÀå±â¿¡ ´ëÇÑ ¸é¿ªÇÐ
_Immunology of Tumors and Transplantation 209
¾Ï¼¼Æ÷ ¹× Á¤»ó ¿Ü·¡¼¼Æ÷¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ
_Immune Responses to Cancer Cells and Normal Foreign Cells

CHAPTER 11 °ú¹Î¹ÝÀÀ_Hypersensitivity 233
¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÑ ½Åü±â´ÉÀÇ Àå¾Ö_Disorders Caused by Immune Responses

CHAPTER 12 ¼±Ãµ ¹× ÈÄõ¸é¿ª°áÇÌÁúȯ_Congenital and Acquired Immunodeficiencies 253
¸é¿ª °áÇÔÀ¸·Î ÀϾ´Â Áúȯ_Diseases Caused by Defective Immunity

Âü°í¹®Çå_Selected Readings 271
¿ë¾îÇؼ³_Glossary 287
APPENDIX I ÁÖ¿ä CDºÐÀÚÀÇ ÇÙ½É Æ¯Â¡_Principal Features of Selected CD Molecules 337
APPENDIX II »çÀÌÅäÄ«ÀÎ_Cytokines 345
APPENDIX III ÀÓ»ó »ç·Ê_Clinical Cases 349
ã¾Æº¸±â_Index 363

°ü·ÃÀ̹ÌÁö

ÀúÀÚ¼Ò°³

Andrew H. Lichtman, Shiv Pillai [Àú] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

±èÆòÇö, ¹Ú¼®·¡, À¯Á¦¿í, À±ÁöÈñ, À̱âÁ¾, Àå¿ë¼® [¿ª] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

Àü°øµµ¼­/´ëÇб³Àç ºÐ¾ß¿¡¼­ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥

    ¸®ºä

    0.0 (ÃÑ 0°Ç)

    100ÀÚÆò

    ÀÛ¼º½Ã À¯ÀÇ»çÇ×

    ÆòÁ¡
    0/100ÀÚ
    µî·ÏÇϱâ

    100ÀÚÆò

    0.0
    (ÃÑ 0°Ç)

    ÆǸÅÀÚÁ¤º¸

    • ÀÎÅÍÆÄÅ©µµ¼­¿¡ µî·ÏµÈ ¿ÀǸ¶ÄÏ »óÇ°Àº ±× ³»¿ë°ú Ã¥ÀÓÀÌ ¸ðµÎ ÆǸÅÀÚ¿¡°Ô ÀÖÀ¸¸ç, ÀÎÅÍÆÄÅ©µµ¼­´Â ÇØ´ç »óÇ°°ú ³»¿ë¿¡ ´ëÇØ Ã¥ÀÓÁöÁö ¾Ê½À´Ï´Ù.

    »óÈ£

    (ÁÖ)±³º¸¹®°í

    ´ëÇ¥ÀÚ¸í

    ¾Èº´Çö

    »ç¾÷ÀÚµî·Ï¹øÈ£

    102-81-11670

    ¿¬¶ôó

    1544-1900

    ÀüÀÚ¿ìÆíÁÖ¼Ò

    callcenter@kyobobook.co.kr

    Åë½ÅÆǸž÷½Å°í¹øÈ£

    01-0653

    ¿µ¾÷¼ÒÀçÁö

    ¼­¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù)

    ±³È¯/ȯºÒ

    ¹ÝÇ°/±³È¯ ¹æ¹ý

    ¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼­ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼­ ½Åû °¡´É

    ¹ÝÇ°/±³È¯°¡´É ±â°£

    º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É
    ´Ü, »óÇ°ÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ À̳»

    ¹ÝÇ°/±³È¯ ºñ¿ë

    º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã
    »óÇ°À̳ª ¼­ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯/¹ÝÇ°Àº ¹Ý¼Û·á ÆǸÅÀÚ ºÎ´ã

    ¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯

    ·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
    (´ÜÁö È®ÀÎÀ» À§ÇÑ Æ÷Àå ÈѼÕÀº Á¦¿Ü)

    ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    ¿¹) È­ÀåÇ°, ½ÄÇ°, °¡ÀüÁ¦Ç°(¾Ç¼¼¼­¸® Æ÷ÇÔ) µî

    ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
    ¿¹) À½¹Ý/DVD/ºñµð¿À, ¼ÒÇÁÆ®¿þ¾î, ¸¸È­Ã¥, ÀâÁö, ¿µ»ó È­º¸Áý

    ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì

    ·ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì

    »óÇ° Ç°Àý

    °ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½

    ¼ÒºñÀÚ ÇÇÇغ¸»ó
    ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó

    ·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê

    ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ

    (ÁÖ)KGÀ̴Ͻýº ±¸¸Å¾ÈÀü¼­ºñ½º¼­ºñ½º °¡ÀÔ»ç½Ç È®ÀÎ

    (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
    (ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼­ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.

    ¹è¼Û¾È³»

    • ±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

    • Ãâ°í°¡´É ½Ã°£ÀÌ ¼­·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.

    • ±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.

    • ¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.

    • - µµ¼­ ±¸¸Å ½Ã 15,000¿ø ÀÌ»ó ¹«·á¹è¼Û, 15,000¿ø ¹Ì¸¸ 2,500¿ø - »óÇ°º° ¹è¼Ûºñ°¡ ÀÖ´Â °æ¿ì, »óÇ°º° ¹è¼Ûºñ Á¤Ã¥ Àû¿ë